Findings

What do systematic reviews say?

39 questions · 39 findings · 7 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 5.1%GRADE not reported 0 · 0%Very low 14 · 35.9%Low 18 · 46.2%Moderate 5 · 12.8%High 0 · 0%

Levetiracetam vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
Very low

Benzodiazepines vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 75 participants
Low

MAOIs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 51 participants
Very low

Comparison 1: 5HT1A partial agonists vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Comparison 9: NaSSAs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Comparison 10: RIMAs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 695 participants
Low

Comparison 12: SNRIs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 261 participants
Low

Comparison 13: SSRIs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 1173 participants
Low

Comparison 2: anticonvulsants/GABAs vs placebo

Reduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD

1 finding from 1 review

Pharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 69 participants
Low

Summary of findings table ‐ DMT vs waiting list control

Neuropsychiatric symptoms · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 137 participants
Low

Summary of findings table ‐ DMT vs exercise

Leaving the study early · dementia or mild neurocognitive disorder

It is very uncertain whether summary of findings table ‐ DMT changes dropouts compared with exercise (very low certainty).

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
OR 0.31 [0.03, 3.09]
1 study · 136 participants
Very low

Summary of findings table ‐ DMT vs waiting list control

Cognitive outcome · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 137 participants
Low

Summary of findings table ‐ DMT vs waiting list control

Depression · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 137 participants
Low

Summary of findings table ‐ DMT vs waiting list control

Social and occupational functioning · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 137 participants
Very low

Summary of findings table ‐ DMT vs waiting list control

Dropout · dementia or mild neurocognitive disorder

It is very uncertain whether summary of findings table ‐ DMT changes dropout compared with waiting list (very low certainty).

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
OR 0.15 [0.02, 1.3]
1 study · 137 participants
Very low

Summary of findings table ‐ DMT vs exercise

Neuropsychiatric symptoms · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Low

Summary of findings table ‐ DMT vs exercise

Cognitive function · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Low

Summary of findings table ‐ DMT vs exercise

Depression · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Low

Summary of findings table ‐ DMT vs exercise

Social and occupational functioning · dementia or mild neurocognitive disorder

1 finding from 1 review

Dance movement therapy for dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 136 participants
Very low